AC Immune SA ACIU

$ 2.98 -0.67%

Annual report 2023
added 10-19-2024

AC Immune SA Financial Statements 2011-2024 | ACIU

Annual Financial Statements AC Immune SA

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	-	305 M	540 M	488 M	286 M	603 M	589 M	-	-	-	-	-
Shares	-	-	75 M	71.1 M	71.1 M	61.8 M	57.1 M	50.1 M	-	-	-	-	-
Historical Prices	3.07	3.05	4.07	7.59	6.87	4.62	10.6	12.4	-	-	-	-	-
Net Income	-	-	-73 M	-61.9 M	45.4 M	-51 M	-26.4 M	-7.1 M	20.3 M	10.7 M	-	-	-
Revenue	14.8 M	3.94 M	-	15.4 M	110 M	6.91 M	20.3 M	23.2 M	39.1 M	30.3 M	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-79 M	-61.3 M	44.5 M	-49.6 M	-22.5 M	-10.5 M	18.6 M	-	-	-	-
Interest Expense	-	-	-	-	1.89 M	298 K	147 K	7 K	-	-	-	-	-
EBITDA	-	-	-79 M	-61.3 M	44.5 M	-49.6 M	-22.5 M	-10.2 M	18.9 M	11 M	-	-	-
Operating Expenses	68.4 M	74.8 M	79 M	76.7 M	65.9 M	56.5 M	42.8 M	33.7 M	20.5 M	19.6 M	-	-	-
General and Administrative Expenses	-	-	17.9 M	11.1 M	9.42 M	7.56 M	6.27 M	4.73 M	2.04 M	2 M	-	-	-

All numbers in CHF currency

Quarterly Income Statement AC Immune SA

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	67.6 M	64.9 M	57.4 M	57.4 M	58.4 M	57.2 M	57 M	56.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14.7 M	-13.5 M	-11.1 M	-11.6 M	4.16 M	-8.79 M	-12.3 M	-9.46 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.4 M	2.3 M	2.03 M	1.46 M	16.4 M	1.07 M	753 K	2.01 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14.5 M	-12.2 M	-11.6 M	-11.3 M	3.19 M	-9.64 M	-8.25 M	-7.83 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14.5 M	-12.2 M	-11.6 M	-11.3 M	3.19 M	-9.64 M	-8.25 M	-7.83 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15.9 M	14.5 M	13.6 M	12.8 M	13.2 M	10.7 M	9.01 M	9.84 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.76 M	2.93 M	3.06 M	2.71 M	3.06 M	2.52 M	2.17 M	2.39 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in CHF currency